Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I see it as a positive, perhaps they are not allowed to shout from the roof tops, we must all wait for the up coming rns. I'm still holding, might even add some more!!! Dyor keep well
The response from Walbrook is no surprise to true LTH’s.
ODX quietly going about their business and ranking up productivity which is now at least 300k per week and stock piling some serious inventory with sales announced to the market when the government is ready. Expecting a very positive results update and forward looking statement. Those that are still holding in jan/feb will be back in the money.
I’m holding and ignoring the short term volatility.
What’s worse? Missing the massive rise to 110p or catching it, making a paper fortune and then painstakingly watching it disappear?
I sold over 600,000 of these shares when it was 38p ish and personally drove the price down to about 33p when I panicked. It was the day before your massive rises about 2 months ago. It’s been painful for me but it did make me think which one is worse?
Keep laughing guys. This share dealing malarkey is not easy in fact it’s a blo ody nightmare. It’s an emotional rollercoaster.
I do wish you all well whatever happens. At the end of the day most here are just working class guys like me.
I don’t think I’m ever going to forget what happened to me though.
You need balls of iron to be in this game.
Lovejoy it's how you decipher the response.
I too think it's full of positive hidden info but of course other may deem it bland and useless.
I'm glad other see it the same way.
Cheers
What a great post, thank you very much, this will give many investors a better night's sleep.
Interesting and inevitable. Article re emerging plans for a digital travel pass https://www.scmp.com/news/world/article/3111100/you-will-need-covid-passport-fly-international-future
How much interest we have had today off the dark side wanting to get in on the cheap.
Pretty dam obvious they want in, nearly 700 post on apparently a company that’s going nowhere you really couldn’t make it up, watch the bounce by Friday aimvho
Thanks handome1. that makes all the difference. Trust in Omega is reinstalled as far as i am concerned.
Upomega.
Today!
Regards
Paul was out of the office Friday and Monday. Back today when I got a similar response
I contacted Walbrook last week and posted the reply here. I can confirm my reply was very similar to Handome1.
Thank for posting this. I believe that the hands are tied for the time being, but this could change any day.
Nice one Handome1. Makes sense for all the radio silence. The government will want to fanfare exclusively anything they have put together themselves. Meanwhile, whilst investors get nervous or bored & move on, CK & the team are quietly expanding & churning out these tests by the bucket load. A series of unfortunate events bring us to where we are but at these prices it's not only CK & the team that are stockpiling.
thanks for sharing handome1. Also did he reply today or previously,
Someone was asking for confirmation earlier of how many doses of the Oxford / AZ vaccine had been pre ordered.
"Oxford University’s collaboration with AstraZeneca has been crucial to the successful development of the vaccine and vital for its global manufacturing and distribution across the world. AstraZeneca already has international agreements in place to supply three billion doses of the vaccine, with access being built through more than 30 supply agreements and partner networks.
https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine
Now, we know that the Oxford / AZ vaccine and the antibody test were developed together - what we need is some evidence that Oxford / AZ could also include / promote / supply this test as an accessory / or add on to their vaccine.
https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine
I believe that £2.5m of the fundraise went on Lateral Flow test tooling to increase production. These tests do not have to be Covid tests.
Comparison of five tests used to detect COVID-19 antibodies shows Siemens and Oxford assays met regulatory targets
The study calculated the sensitivity (the ability of a test to correctly identify those with SARS-CoV-2 antibodies or ‘true positive’ rate) and the specificity (the ability of the test to correctly identify those without SARS-CoV-2 antibodies or ‘true negative’ rate).
https://www.ox.ac.uk/news/2020-09-28-comparison-five-tests-used-detect-covid-19-antibodies-shows-siemens-and-oxford
Paul posted these replies..
In terms of MHRA approval – this process is being led by Abingdon who are in dialogue with the MHRA. Any public statement by a consortium member would need to be approved by Abingdon and most likely also agreed with the MHRA. Abingdon and the UK-RTC are unlikely to approve a public update on a process that might prejudice or negatively impact that process.
In terms of Government orders – the UK-RTC announced on 6 October the first order for 1m tests from the DHSC. This was an agreed statement that had been pre-approved by the UK Government Comms teams and reflects the purchase order raised for the first 1m tests. As yet the UK-RTC has not received further orders under the framework agreement with the DHSC but as and when they do then a statement would be made by the UK-RTC and by Omega as a listed company. No doubt any public statements would require approval from UK Government Comms teams in the same way, but also they would be aware of the obligations of Omega (and potentially Abingdon if they go ahead with their IPO) to inform the markets of any substantial orders without due delay. Also, should there be conversations between any parties and the UK Government about Lateral flow antigen tests then it’s highly likely that no public statements could be made either without Government approval.
In terms of the connection between the UK-RTC test and the Oxford AZ vaccine – the UK-RTC has stated previously that the AbC-19 Rapid Test and the Oxford University vaccine candidate both target the same antibody response to SARSCoV- 2. UK-RTC researchers developing the AbC-19 Rapid Test had access to the SARS-CoV-2 antigens used by the Oxford research teams, ensuring both the assay and the vaccine target the same antibody response. Omega is again limited to what it can say on its own being part of the UK-RTC. There is no contractual relationship between the role out of the Oxford vaccine and the AbC-19 Rapid test and Omega wouldn’t want to be misleading about potential deployment. Nevertheless the UK-RTC will certainly be leveraging the connections mentioned above both in their existing supply agreement with the UK Government and with other third parties via their own marketing and commercial promotion.
Obviously Walbrook can only provide updates on Omega products and orders as and when the Company have news to give to investors. There will be an update on 30 November at the results and hopefully there will be future news on a number of items for the business that we can provide as and when they can be announced.
Kind regards,
Paul.
Regarding gov orders he says "as and when" not if and when.
I wonder what percentage of the fundraise from earlier in the year, will actually be used for Covid products?
That will obviously depend on UKRTC sales and if Malogic gets off the ground.
The
*Mologic
If the Molotov antigen comes in then they will part
camkite
that is very interesting. that could mean that abingdon will be valued higher than omega. which would make sense if they are going to take over omega
I think its because of 2 things
The possibility of Abingdon listing with a smaller Mcap than ODX
The fact that those funding the Abingdon ipo will likely on the large part be ODX holders, selling up here to help fund it.
Aimo.
Not sure if anyone has posted this, but bbi have 9 vacancies all for covid antibody home testing.At least they are still there even if they may be old. So hopefully bodes well for future orders. Especially as they mention vaccines. Even though not worded as support for vaccine survalence
Not a regular poster but I think some on this board operate in a world of wishful thinking rather than considering the facts.
Sentiment has driven this share to the dizzy heights of a £1 plus. Sentiment has changed and now all the focus in the media is on the vaccine. it's only natural that sentiment will change direction whether testing is needed or not hence the drop in SP had to be expected.If you listen closely to the investor presentation CK seems far more bullish on the CD4 and Food intolerance tests in China etc and he has stated that this is where he seems his greatest revenue moving forward especially where they have the only product with IP protection. He's made a point of saying they are not just a Covid company. For me, I can't see a Covid based spike on the horizon.
This is still a £5 share all day long for me and no one will convince me otherwise. I believe huge orders will roll in as soon as the vaccines are signed off esp AZ/Oxford and we will be booked at full capacity for months on end. Patience and conviction is all that is needed here and you will reap the rewards. If it goes to 40 tomorrow so be it, it’s all irrelevant if you believe in your investment. This isn’t a ramp, I hate all the ramping nonsense, this is facts, these tests are needed in the billions, end of.